Current PSA level-Between 10 to 20 - Page 3 of 5 Posts on Medivizor
Navigation Menu

Current PSA level-Between 10 to 20 Posts on Medivizor

Adding radiation to hormone therapy is effective for locally advanced prostate cancer

Adding radiation to hormone therapy is effective for locally advanced prostate cancer

Posted by on Jun 6, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the benefit of combining radiation therapy with androgen deprivation therapy (ADT) in older men and in men with aggressive cancer cells. Researchers reported reduced mortality risks with combination therapy in all groups studied.  Some background Radiation therapy is a common treatment for localized...

Read More

Searching for men with early stage prostate cancer to test a short course of very focused radiation therapy

Posted by on May 9, 2016 in Prostate cancer | 0 comments

In a nutshell This phase 1/2 trial aims to evaluate the effectiveness of a short course of very focused radiation therapy in the treatment of early stage prostate cancer. The main outcome to be investigated is side effects and treatment response. The trial is recruiting in San Diego, California (USA). The details External beam radiation therapy...

Read More

Should hormone therapy be added to intensive radiotherapy in early prostate cancer?

Should hormone therapy be added to intensive radiotherapy in early prostate cancer?

Posted by on Jan 31, 2016 in Prostate cancer | 0 comments

In a nutshell This study examined the potential benefit of early hormone therapy added to intensive radiotherapy in the treatment of men with intermediate-risk local prostate cancer. Overall survival was found to be improved with higher radiation dosage. However, the researchers noted that early hormone therapy does generally not benefit treatment...

Read More

Looking for patients with metastatic hormone-resistant prostate cancer to evaluate the benefit of using immunotherapy and radiation

Looking for patients with metastatic hormone-resistant prostate cancer to evaluate the benefit of using immunotherapy and radiation

Posted by on Sep 25, 2015 in Prostate cancer | 0 comments

In a nutshell This phase II trial based in Dallas, Texas aims to determine the effect of immunotherapy and stereotactic ablative body radiation as a metastatic hormone-resistant prostate cancer treatment. The main outcome to be investigated is time from treatment until cancer progression.  The details Metastatic prostate cancer is cancer that...

Read More

Looking for prostate cancer patients who have had their prostate removed to determine the safety of a shorter course of radiation

Posted by on Jul 27, 2015 in Prostate cancer | 0 comments

In a nutshell This phase I/II trial aims to determine the safety of administering shorter courses of radiation over a shorter period of time to patients who have had their prostate removed. The main outcome to be investigated is dose safety and toxicity in patients and to determine quality of life benefits.  The details Radiation therapy...

Read More

The effect of standard treatments in patients with favorable and unfavorable prostate cancer

Posted by on Jun 7, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the effect of common treatments on prostate cancer-specific mortality for patients with intermediate-risk prostate cancer.  Some background Intermediate-risk prostate cancer is cancer that has grown through and/or out of the prostate. It can be further classified as favorable or...

Read More

Identifying prostate cancer progression

Posted by on Apr 29, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to identify the best options available to identify metastatic prostate cancer. Some background Metastatic prostate cancer is cancer that has spread from the prostate gland into tissues and organs around the body. In some cases patients with metastatic cancer can become resistant to certain treatments, such as...

Read More

Comparing urinary incontinence and erectile dysfunction as side effects after robotic vs. open prostate removal

Comparing urinary incontinence and erectile dysfunction as side effects after robotic vs. open prostate removal

Posted by on Apr 28, 2015 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate the complications associated with robotic-assisted prostate removal (minimally invasive) compared to an open surgical procedure (more invasive).   Some background Open surgical removal of the prostate has previously been the traditional surgical approach for prostate cancer treatment. Robot-assisted...

Read More